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The Author Replies: In their letters to the editor, two groups,
from Los Angeles1 and Saitama, Japan,2 respectively, raised
some concerns regarding the methodology and the results of
our previously published study on renal blood oxygen level–
dependent magnetic resonance imaging (BOLD-MRI) in a
non-selected patient group. The current literature on renal
BOLD-MRI and its applications presents heterogeneous
results regarding the correlation between R2* and the
estimated glomerular ﬁltration rate.3,4 These different
results are most likely due to a lack of understanding of the
complex interaction between the different types of renal
diseases, their speciﬁc pathophysiology, and the complex
magnetic resonance (MR) signal generation. The choice of
shorter echo times in our study is surely not a relevant factor
explaining the differences between our ﬁndings and the
ﬁndings of other research groups. In contrast, the use of 3T
MR mandates the use of shorter echo times to yield reliable
image quality even with the longest echo time used.5 In
addition, similar echo times as in our study have also been
used by the group of Prasad et al., who pioneered the ﬁeld of
renal BOLD-MRI. Much more interesting than these
technical details are the implications of our study that have
been addressed by the authors of these letters. We concur that
our study does not imply that BOLD-MRI of the kidneys
should not be done. The main conclusion of our study was
that ‘broad application of renal BOLD MRI seems not
suitable’.3 The use of BOLD imaging in dedicated patient
groups should not be discouraged. In contrast, further studies
in patient groups with similar pathophysiological changes or
intraindividual studies are warranted. Under these premises
the inﬂuence of altered microvascular density or of the red
blood cell count and altered medications could be better
controlled. Novel approaches for image analysis of the
parametric R2* maps, such as the suggested region-
of-interest–based histogram plot, might further provide better
insights into pathology.
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Drug use and nephrotoxicity in
the intensive care unit: are we
under-dosing antimicrobials in
patients with acute kidney injury
with the need of extended
dialysis?
To the Editor: An important aspect that we would like to
raise, in addition to what Dr Perazella described as drug dose
adjustment1 in a recent review in this journal, is the use of
antibiotics in extended dialysis (ED). With ED, patients with
acute kidney injury have a potentially supraphysiologic drug
clearance during ED procedures, and this may be detrimental
in patients for whom bactericidal concentrations of antibiotics
are needed. Therefore, when the antibiotic is given in relation to
ED may be as important as the dosing. This premise has been
demonstrated by Lorenzen et al.,2 who reported that ampicillin/
sulbactam given too early or late in relation to ED could result
in supra- or subtherapeutic concentrations. Also considered
should be the pharmacodynamic properties of the antimicrobial
in question. Antimicrobials require speciﬁc attention to their
pharmacodynamic activity, as drugs that are time-dependent
killers may require a different timing and dosing compared
with those that kill in a concentration-dependent manner.3
Taking these considerations into account may be difﬁcult
enough, but complexity is added by the intensive care unit
(ICU) environment, to which access is limited, and procedures
may interfere with drug and dialysis scheduling.
In addition, there is paucity in dosing information of several
antibiotics commonly used in the ICU in patients with ED. ED
pharmacokinetics has been conducted in very few drugs.4
We agree with Dr Perazella that dosing of medications in
critically ill patients with acute renal replacement therapy is
challenging, and that practitioners should seek best evidence
and adjust their recommendation of dialysis parameters and
timing to optimize the dosing of antimicrobials.
1. Perazella MA. Drug use and nephrotoxicity in the intensive care unit.
Kidney Int 2012; 81: 1172–1178.
2. Lorenzen JM, Broll M, Kaever V et al. Pharmacokinetics of ampicillin/
sulbactam in critically ill patients with acute kidney injury undergoing to
extended dialysis. Clin J Am Soc Nephrol 2012; 7: 385–389.
Kidney International (2012) 82, 934–937 935
l e t t e r to the ed i to r
